Detailed information for compound 1370290

Basic information

Technical information
  • TDR Targets ID: 1370290
  • Name: methyl 3-[[4-(4-ethoxycarbonylpiperazine-1-ca rbonyl)phenyl]methyl]-4-oxo-2-sulfanylidene-1 H-quinazoline-7-carboxylate
  • MW: 510.562 | Formula: C25H26N4O6S
  • H donors: 1 H acceptors: 4 LogP: 2.08 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 2
  • SMILES: CCOC(=O)N1CCN(CC1)C(=O)c1ccc(cc1)Cn1c(=S)[nH]c2c(c1=O)ccc(c2)C(=O)OC
  • InChi: 1S/C25H26N4O6S/c1-3-35-25(33)28-12-10-27(11-13-28)21(30)17-6-4-16(5-7-17)15-29-22(31)19-9-8-18(23(32)34-2)14-20(19)26-24(29)36/h4-9,14H,3,10-13,15H2,1-2H3,(H,26,36)
  • InChiKey: LHLMXMURWHKMER-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • methyl 3-[[4-(4-ethoxycarbonylpiperazine-1-carbonyl)phenyl]methyl]-4-oxo-2-thioxo-1H-quinazoline-7-carboxylate
  • 3-[[4-[(4-ethoxycarbonyl-1-piperazinyl)-oxomethyl]phenyl]methyl]-4-oxo-2-thioxo-1H-quinazoline-7-carboxylic acid methyl ester
  • 3-[4-(4-carbethoxypiperazine-1-carbonyl)benzyl]-4-keto-2-thioxo-1H-quinazoline-7-carboxylic acid methyl ester
  • methyl 3-[[4-(4-ethoxycarbonylpiperazin-1-yl)carbonylphenyl]methyl]-4-oxo-2-sulfanylidene-1H-quinazoline-7-carboxylate
  • ChemDiv1_013328
  • Oprea1_724461

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens lysine (K)-specific methyltransferase 2A Starlite/ChEMBL No references
Homo sapiens ataxin 2 Starlite/ChEMBL No references
Homo sapiens GNAS complex locus Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Toxoplasma gondii histone lysine methyltransferase SET1 Get druggable targets OG5_130642 All targets in OG5_130642
Echinococcus granulosus guanine nucleotide binding protein Gs subunit Get druggable targets OG5_131088 All targets in OG5_131088
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative Get druggable targets OG5_131088 All targets in OG5_131088
Schistosoma japonicum ko:K09188 myeloid/lymphoid or mixed-lineage leukemia protein 3, putative Get druggable targets OG5_130642 All targets in OG5_130642
Echinococcus granulosus guanine nucleotide binding protein Gs subunit Get druggable targets OG5_131088 All targets in OG5_131088
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) Get druggable targets OG5_131088 All targets in OG5_131088
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain Get druggable targets OG5_131088 All targets in OG5_131088
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit Get druggable targets OG5_131088 All targets in OG5_131088
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit Get druggable targets OG5_131088 All targets in OG5_131088
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) Get druggable targets OG5_131088 All targets in OG5_131088
Schistosoma japonicum ko:K04632 guanine nucleotide binding protein (G protein), alpha stimulating, putative Get druggable targets OG5_131088 All targets in OG5_131088
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) Get druggable targets OG5_131088 All targets in OG5_131088
Schistosoma mansoni mixed-lineage leukemia protein mll Get druggable targets OG5_130642 All targets in OG5_130642
Neospora caninum Multidomain chromatinic protein with the following architecture: 3x PHD-bromo-3xPHD-SET domain and associated cysteine cluster a Get druggable targets OG5_130642 All targets in OG5_130642
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Schistosoma mansoni GTP-binding protein alpha subunit gna GNAS complex locus 394 aa 450 aa 28.7 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus granulosus histone lysine N methyltransferase MLL3 0.0011 0.0939 0.0453
Trichomonas vaginalis conserved hypothetical protein 0.0008 0.0525 1
Echinococcus granulosus cpg binding protein 0.0037 0.4678 0.6015
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0055 0.7357 0.7328
Loa Loa (eye worm) CXXC zinc finger family protein 0.0035 0.4393 0.5381
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0008 0.0525 1
Trichomonas vaginalis conserved hypothetical protein 0.0008 0.0525 1
Schistosoma mansoni hypothetical protein 0.0014 0.1361 0.1265
Plasmodium vivax ataxin-2 like protein, putative 0.003 0.3781 0.5
Loa Loa (eye worm) hypothetical protein 0.003 0.3781 0.4428
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0.3781 0.5
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0008 0.0525 1
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0008 0.0525 1
Echinococcus multilocularis Ataxin 2, N terminal,domain containing protein 0.0014 0.1361 0.108
Trichomonas vaginalis conserved hypothetical protein 0.0008 0.0525 1
Trichomonas vaginalis conserved hypothetical protein 0.0008 0.0525 1
Brugia malayi hypothetical protein 0.003 0.3781 0.4445
Trichomonas vaginalis chromodomain-helicase-DNA-binding protein, putative 0.0008 0.0525 1
Echinococcus multilocularis cpg binding protein 0.0037 0.4678 0.6015
Brugia malayi CXXC zinc finger family protein 0.0035 0.4393 0.5396
Trichomonas vaginalis helicase, putative 0.0008 0.0525 1
Toxoplasma gondii histone lysine methyltransferase SET1 0.0066 0.8867 1
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0008 0.0525 1
Plasmodium falciparum ataxin-2 like protein, putative 0.003 0.3781 0.5
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0055 0.7357 0.7328
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0055 0.7357 1
Trichomonas vaginalis conserved hypothetical protein 0.0008 0.0525 1
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0.3781 0.5
Trypanosoma brucei PAB1-binding protein , putative 0.003 0.3781 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0008 0.0525 1
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0055 0.7357 1
Plasmodium falciparum ataxin-2 like protein, putative 0.003 0.3781 0.5
Schistosoma mansoni cpg binding protein 0.0037 0.4678 0.4619
Leishmania major hypothetical protein, conserved 0.003 0.3781 0.5
Brugia malayi hypothetical protein 0.002 0.2226 0.2029
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0008 0.0525 1
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0055 0.7357 1
Schistosoma mansoni cpg binding protein 0.0037 0.4678 0.4619
Trichomonas vaginalis conserved hypothetical protein 0.0008 0.0525 1
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0055 0.7357 1
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0055 0.7357 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0055 0.7357 0.7328
Trichomonas vaginalis chromodomain-helicase-DNA-binding protein, putative 0.0008 0.0525 1
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0008 0.0525 1
Schistosoma mansoni mixed-lineage leukemia protein mll 0.0009 0.0634 0.0531
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0055 0.7357 1
Trichomonas vaginalis conserved hypothetical protein 0.0008 0.0525 1
Echinococcus granulosus Ataxin 2 N terminaldomain containing protein 0.0014 0.1361 0.108
Schistosoma mansoni cpg binding protein 0.0035 0.4393 0.4331
Trichomonas vaginalis conserved hypothetical protein 0.0008 0.0525 1
Onchocerca volvulus 0.0035 0.4393 0.5
Echinococcus multilocularis histone lysine N methyltransferase MLL3 0.0011 0.0939 0.0453

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 0.1122 uM PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 3.5481 um PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)] ChEMBL. No reference
Potency (functional) 3.5481 uM PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 10 uM PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 14.7157 uM PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] ChEMBL. No reference
Potency (functional) 18.526 uM PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] ChEMBL. No reference
Potency (functional) 29.081 uM PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] ChEMBL. No reference
Potency (functional) 30.1313 uM PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Plasmodium falciparum ChEMBL23

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.